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Abstract
While a tight seal and fixation of aortic stent-grafts to the vessel wall are vital for posi-
tive outcomes in treating abdominal aortic aneurysms (AAAs), optimal aortic stent-graft 
sizing for endovascular aneurysm repair (EVAR) remains debatable. We performed a 
holistic review of the data surrounding the sizing of endografts using instructions for 
use (IFU) guidelines, as well as experimental, computational, and clinical studies. Most 
clinical studies that have investigated the role of sizing and outcomes are limited by the 
strict selection criteria, or the inability to account for the multitude of confounders associ-
ated with sizing. Currently, oversizing of endografts between 10 and 20% remains safe 
and favored, but sizing outside the IFU guidelines frequently occurs. Oversizing up to 
25% appears to be associated with decreased rates of proximal endoleak and aneurysm 
sac enlargement, while excessive oversizing (>30%) has been linked to graft infolding, 
collapse, and aortic dilatation. It is unclear, however, whether there is an association 
between oversizing associated with neck dilatation and graft migration. During sizing, 
surgeons should take an individual approach and consider several factors including 
device type, calcification and/or thrombus of apposition site, hemodynamics, and aor-
toiliac morphology.
Keywords: endovascular aneurysm repair, sizing, endograft, instructions for use, 
abdominal aortic aneurysm
1. Introduction
Aortic aneurysms, a ballooning of a weakened portion of the aorta, are most frequently 
seen in the abdominal aorta. When indicated, an abdominal aortic aneurysm (AAA) can be 
treated with open surgical or endovascular repair. With a higher perioperative morbidity 
and mortality of open surgery [1–6], endovascular aneurysm repair (EVAR) of the abdomi-
nal aorta has grown in popularity as a safe, effective, and minimally invasive alternative 
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for certain patients. The goal of EVAR is to achieve adequate fixation and to seal the stent 
graft to the vessel wall, thus redirecting blood flow away from the pathologic section of the 
aorta n/a. Failure to do so can result in several noteworthy complications, including device 
migration or kinking, dilatation, and most commonly perigraft endoleak. In fact, some have 
reported endoleak complications in up to 20–25% of patients following the EVAR [7, 8]. 
Ultimately, these complications can lead to occlusion of adjacent branches, aneurysm sac 
growth, or even rupture.
Exploration of the use of nonporous endoprosthesis for the treatment of AAA dates back to 
1976, when Parodi et al. [9] began to transform Dacron prosthetics into intraluminal devices. 
Several others went on to test the intraluminal grafts in animals with an array of sizing pro-
tocols [10–13]. However, it is difficult to interpret sizing practices from these early studies 
since most involved balloon-expandable stents and not the self-expandable stents that are 
frequently used today. Since the approval of self-expandable aortic stent-grafts in humans 
with AAAs over a decade ago, sizing has become a crucial component of the successful EVAR. 
Early feasibility studies recommended sizing the device larger than the vessel (i.e., oversiz-
ing) without strong scientific backing. After years of use, evidence for oversizing has been 
validated [14, 15]. Oversizing helps in securing the device in place and achieving adequate fix-
ation and seal by increasing the frictional force between the vessel and device. Additionally, 
oversizing addresses the unevenness of each vessel and allows the vessel to take the circular 
shape of the device [16]. Ultimately, the device must generate a large enough radial force to 
resist displacement from the vessel wall, but not so large that the endograft starts to fold or 
cause adverse vessel remodeling.
Although most surgeons agree about the importance of sizing, several factors make it a dif-
ficult task. For one, angulated vessels may introduce variability in the degree of oversizing 
delivered around the vessel wall. Others include the presence of thrombus or calcification at 
the attachment sites, length and shape of apposition sites, graft features, and stability of ves-
sels. Further complicating, sizing is the reality that the pulsatility of vessels and hemodynam-
ics of each patient is variable. Nevertheless, the instructions for use (IFU) guidelines of most 
devices recommend sizing the endovascular graft 10–20% larger than the vessel diameter. 
However, these sizing recommendations lack comparable safety and effectiveness studies for 
aortic grafts sized outside that range. Moreover, graft oversizing in patients frequently varies 
from the manufacturer’s IFU, with reported oversizing ranging from less than 5% to greater 
than 40% [17]. With this variability, and because the complication rate post EVAR remains sig-
nificant, the optimal degree of oversizing continues to be a topic of interest for many surgeons.
2. Aim of the chapter
The aim of this chapter is to provide physicians with a useful resource when sizing stent-
grafts for EVAR of the abdominal aorta. This chapter provides the instructions for use guide-
lines published by each graft manufacturer and objectively reviews the relationship between 
the endograft sizing and outcomes using experimental, computational, and clinical studies.
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3. Early development and sizing
The difficulty of sizing prosthesis can be seen as early as the implantation of sutureless intra-
luminal grafts during open surgery. With the goal of better fixation, Matsumae et al. [18] pro-
posed the addition of elastic rings and saw no dislodgment or migration in nine canines with 
a ratio of 0.92–0.70 (31.4%) of ring to aorta diameter. In 1983, Nitinol wires were inserted in 
animals using a transluminal approach with only the stent dimensions reported [19, 20]. Since 
wires were not a feasible solution to exclude the aneurysm sac, several attempts were made 
testing intraluminal grafts in animals [9–13]. Balko et al. [10] used 10 mm intraluminal poly-
urethane prosthesis with a compressible Nitinol wire frame in a 9 mm self-made aneurysm 
in sheep. Laborde et al. [13] used 10 mm modified tubular Dacron grafts affixed to balloon-
expandable stents and applied it to 10 mm mongrel vessels and found inconsistent results; 
yet, they recommended expanding the stent to a diameter 10–15% larger than the aorta. In 
1991, Parodi et al. [9] achieved a “watertight seal” in humans using a balloon-expandable 
stent, but unfortunately, the sizing of each patient was not reported. Soon after, several stud-
ies investigated the anatomy of patients with AAA in order to identify the range of endograft 
sizes necessary for treatment [21, 22]. Thus, the importance of accurately sizing endografts 
was clear early on. Manufacturers of these early grafts recommended that stent-grafts should 
be oversized a few millimeters. It is not clear, however, what scientific observations were 
used to make these recommendations. Even in 1999, an experimental study reported that 
they supported the “theoretical” advantage of oversizing prosthesis [15]. Nevertheless, these 
early feasibility studies highlight how oversizing has been an important part of EVAR since 
the early development.
4. Endograft devices and instructions for use
Since the first device implanted in patients in 1991, several modifications have been made 
with efforts to address access, fixation, and sealing. Devices can be classified as either bal-
loon- or self-expandable. The most commonly used devices today are self-expandable and 
they have the advantage of providing more anatomically correct support. The manufacturers 
of approved endografts suggest measuring either from intima to intima (inner wall) or adven-
titia to adventitia (outer wall). Thus, when deciding how much to oversize, the apposition site 
diameter measurements should be device-specific. The following consists of a brief timeline 
of the currently available self-expandable devices.
In 1999, the Food and Drug Administration (FDA) first approved the use of two self-expand-
able endografts, the AneuRx (Medtronic Vascular, Santa Rosa, CA, USA) and Ancure (Guidant 
Corporation, Indianapolis, IN, USA). Yet, by 2001, Guidant suspended the production and 
announced the recall of all Ancure devices. In 2002 and 2003, respectively, the Excluder 
(W.L. Gore & Associates, Flagstaff, AZ, USA) and Zenith (Cook Inc., Bloomington, IN, USA) 
devices gained approval. More recently, the Powerlink (Endologix, Irvine, CA, USA), Talent 
(Medtronic, Inc., Minneapolis, MN, USA), and Endurant (Medtronic, Inc., Minneapolis, MN, 
USA) devices were all approved. The characteristics of each device currently available along 
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with their recommended sizing protocols are given below (Table 1). The associated exclusion 
criteria, study designs, and outcomes from their clinical trials are also summarized (Table 2). 
Of note, the anatomical requirements for inclusion in these studies are often strict and do 
not represent the scope of patients currently being treated with EVAR. Thus, the anatomical 
characteristics of each study should be considered when evaluating the degree of oversizing 
used. Finally, by proving safety and effectiveness, many of these studies helped in guiding 
the recommendations for the endograft sizing today. What they did not show, however, was 
the effect of different levels of sizing on outcomes. In general, the instructions for use recom-
mendations suggest using an individual approach and oversizing stent-grafts 10–20% in the 
abdominal aorta with a wider accepted range of up to 25% in the iliac arteries.
Device Design Active fixation Suprarenal or 
infrarenal
Available sizes Sizing 
recommendation
AneuRx 
(Medtronic, Inc.)
Modular, 
bifurcated, Nitinol 
stent, polyster 
fabric
No Infrarenal Main body: 
20–28 mm, iliac 
limb: 12–24 mm
Approximately 2 mm 
larger than the aortic 
diameter and 1 mm 
larger iliac diameter 
(10–20% oversizing)—
see IFU
Excluder (W.L. 
Gore & Associates, 
Inc.)
Modular, 
bifurcated, Nitinol 
stent, ePTFE fabric
Yes (anchors) Infrarenal Main body: 
23–31 mm, iliac 
limb: 10–20 mm
At least 2 mm larger 
than the aortic inner 
diameter (10–21% 
oversizing) and 1 mm 
larger than the iliac 
inner diameter (7–25% 
oversizing)—see IFU
Zenith (Cook 
Medical, Inc.)
Modular, 
bifurcated, stainless 
steel Z-stents, 
polyster Dacron 
fabric
Yes (barbs) Suprarenal Main body: 
22–36 mm, iliac 
limb: 8–24 mm
Varying based on 
outer diameter 
aortic: (14–24%) iliac: 
(0–20%)—see IFU
Powerlink 
(Endologix)
Modular, 
bifurcated unibody, 
cobalt chromium 
stent, ePTFE
No Infrarenal Main body: 
25–28 mm, iliac 
limb: 16 mm, 
extenstion limb: 
16–25 mm
Varying based on 
diameter—see IFU
Talent (Medtronic, 
Inc.)
Modular, 
bifurcated, nitinol 
stent, polyster 
fabric
No Suprarenal Main body: 
22–36 mm, iliac 
limb: 8–24 mm
Varying based on 
diameter aortic: 
(14–24%) iliac: 
(0–20%)—see IFU
Endurant 
(Medtronic, Inc.)
Modular, 
bifurcated or 
aorta-uniiliac, 
Nitinol M-shaped 
stent, high filament 
polyster fabric
Yes (pins) Suprarenal Main body: 23–36 
mm, iliac limb: 
10–28 mm
Aorta: 10–20% larger 
than vessel inner 
diameter iliac: 10–25% 
larger than vessel 
inner diameter—see 
IFU
ePTFE, expanded polytetrafluoroethylene.
Table 1. Characteristics of commercially available self-expandable aortic stent-grafts.
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Device FDA 
approval
Clinical study 
sizing
Study design N Follow-up Patients excluded Anatomical 
characteristics
Outcomes
AneuRx 1999 Not specified 
(recommended 
10–20% overisizing)
Nonrandomized, 
prospective, 
multicenter clinical 
study
416 6 months, 
1 year
• Aneurysmal neck or 
proximal neck length 
<10 mm
• Infrarenal neck 
diameter <18 mm or 
>26 mm
• Neck angluation >60°
• Iliac diameter >16 mm
• Iliac landing zone 
length <15 mm
• Vessel morphology 
not suitable for 
endovascular repair
• Median neck 
diameter 20–29 mm
Migration
Predischarge—baseline
6 months—1.7%
1 year—1.6%
• Median aneurysm 
diameter 50–59 mm
Endoleak (any)
Predischarge—43.8%
6 months—24%
1 year—17.4%
Excluder/low 
permeability 
excluder*
2002/2004 Not specified 
(recommended 
10–21% overisizing 
aorta and 7–25% 
iliacs)
Nonrandomized 
prospective, 
multicenter clinical 
studies
563/139* 1 month, 
6 months, 
1 year, 
2 years, 
3 years, 
4 years, 
5 years
• Infrarenal proximal 
neck lengh <15 mm
• Infrarenal aneurysmal 
aortic neck or 
diameter > 29 mm
• Proximal neck 
angulation >60°
• Presence of significant 
thrombus at 
implantation sites
• Iliac and femoral 
arteries not suitable for 
EVAR
• Vessel morphology 
not suitable for 
endovascular repair
• Median aneurysm 
diameter 50–59 mm
Migration
month—0%; 
6 months—0.4%; 
1 year—0.7%; 
>2 years—0%
Endoleak (any; type 1)
1 month—27.3%, 2.6%
6 months—25.5%, 2.6%
1 year—22.5%, 0.4%
2 years—21.9%, 0.9%
3 years—22.1%, 1.2%
4 years—20.5%, 1.0%
5 years—16.4%, 0.8%
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Device FDA 
approval
Clinical study 
sizing
Study design N Follow-up Patients excluded Anatomical 
characteristics
Outcomes
Zenith 2003 Not specified 
(recommended 
14–24% oversizing 
aorta and 0–20% 
iliacs)
Nonrandomized, 
prospective, 
multicenter clinical 
studies
352 (200 
standard, 
100 high 
risk, 52 
roll-in)
1 month, 
6 months, 
1 year
• Infrarenal proximal 
neck length <15 mm
• Infrarenal neck outer 
diameter <18 mm or 
>32 mm
• Suprarenal angulation 
>45° or infrarenal 
angulation >60°
• Iliac diameter <7.5 mm 
or >20 mm
• Iliac length <10 mm
• Vessel morphology 
not suitable for 
endovascular repair
• Median aneurysm 
diameter 50–59 mm
Migration (>5 mm and 
without sequel)
1 year—2.5%, 2.8%, 0% 
(standard, high risk, 
roll in)
Endoleak (any)
1 year—7.4%, 8.8%, 
3.4% (standard, high 
risk, roll in)
Powerlink 2004 10–20% relative to 
the neck diameter
Nonrandomized, 
prospective, 
multicenter clinical 
studies
192 1 month, 
6 months, 
1 year
• Infrarenal proximal 
neck length <15 mm
• Infrarenal neck 
diameter <18 mm or 
>26 mm
• Neck angluation >60°
• Iliac artery diameter 
<7 mm
• Iliac landing zone 
length <15 mm
• Vessel morphology 
not suitable for 
endovascular repair
• Aneurysm diameter 
51 ± 6.6 mm
• Proximal seal 
zone length  
29.3 ± 11.3 mm
• Right iliac diameter 
12.3 ± 2.3 mm
• Left iliac diameter 
12.1 ± 1.8 mm
Migration (>5 mm 
without sequel)
1 year—4.4%
Endoleak (any; new 
type I)
1 month—22.7%, 0.8%
6 months—12.9%, 0%
1 year—14.1%, 0%
2 year—4.9%
Aortic Aneurysm
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approval sizing characteristics
Talent 2008 Not specified 
(recommended 
14–24% oversizing 
aorta and 0–20% 
iliacs)
Nonrandomized, 
prospective, 
multicenter clinical 
studies
166 1 month, 
6 months, 
1 year
• Infrarenal proximal 
neck length of <10 mm
• Infrarenal proximal 
neck diameter <18 mm 
or >32 mm
• Neck angulation >60°
• Iliac artery diameter of 
<8 mm or >22 mm
• Iliac artery length of 
<15 mm
• Vessel morphology 
not suitable for 
endovascular repair
• Aneurysm diameter 
51 ± 6.6 mm
• Proximal seal 
zone length 
29.3 ± 11.3 mm
• Right iliac diameter 
12.3 ± 2.3 mm
• Left iliac distal 
diameter 
12.1 ± 1.8 mm
Migration
1 year—0.8%
Endoleak (any; type I)
1 month—19.3%, 9.3%
1 year—9.2%, 2.5%
Endurant/
endurant II**
2010/2012 Approximately  
20% greater than 
inner diameter
Nonrandomized, 
prospective, 
multicenter clinical 
studies
150 1 month, 
6 months, 
1 year
• Infrarenal proximal 
neck length <10 mm or 
significant calcification 
or thrombus
• Proximal neck diameter 
<19 mm or >32 mm
• >45° suprarenal or >60° 
infrarenal neck angles
• Iliac fixation site 
diameter <8 mm or 
>25 mm
• Aneurysmal iliac 
arteries or lengths <15 
mm
• Vessel morphology 
not suitable for 
endovascular repair
• Aneurysm diameter 
55.9 ± 8.7 mm
• Proximal neck length  
31.0 ± 14.3 mm
• Proximal 
neck diameter 
23.5 ± 3.0 mm
• Suprarenal angle 
16.0 ± 10.3°
• Infrarenal angle 
35.2 ± 13.7°
• Right iliac diameter 
14.2 ± 42 mm
• Left iliac diameter 
13.9 ± 3.1 mm
Migration
1 year 0%
Endoleak (any; type I)
1 month—16.1%, 0%
6 months—11.6%, 0%
12 months—9.8%, 0%
Modifations to the original Gore Excluder were made and tested because of aneurysm enlargement rates.
New delivery system with extended hydrophilic coating, two new limb lengths, new radiopacity on contralateral gate.
Table 2. Instructions for use—clinical studies.
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5. Clinical outcomes and oversizing
The goal of EVAR is a long-term exclusion of the aneurysm, without any complications such 
as graft migration or endoleak. Obtaining a tight seal and adequate fixation are important 
in lowering intrasac pressure and limiting further disease progression. In 2009, a systematic 
review evaluated the relationship between oversizing and outcomes and reported that 10–20% 
oversizing is relatively safe and remains as the preferred sizing choice of surgeons [17].
5.1. Biomechanics and vessel remodeling
Understanding the effects of EVAR on both the vessel wall and device itself is important for 
making improvements in endovascular surgery. Several authors have attempted to investi-
gate these consequences with specific consideration to the effects of oversizing. When a stent 
is apposed to an artery, the force created from the vessel wall opposes a stent’s outward radial 
force. After deployment, equilibrium is achieved between the vessel and stent-graft where the 
radial force is proportional to the final diameter of the incorporated device [23]. Thus, radial 
force is significantly correlated with the degree of oversizing. If the force delivered to the ves-
sel exceeds the equilibrium, it is plausible that the inward folding (i.e., infolding) or collapse 
of the graft can occur. In turn, infolding of the graft at its border can result in new interfaces 
between the blood flow and the graft, thus resulting in an increased risk of migration. In fact, 
excessive oversizing, in particular greater than 30%, has been linked to infolding of the device 
[24, 25]. In further analysis, Lin et al. [26] showed significantly less likelihood of folding when 
oversized below 23.5%. Interestingly, when stents collapse they do so asymmetrically. This 
has been shown in vitro where certain areas of the stent have more rigidity and thus takes on 
more force [23].
Another potential consequence of the radial force delivered to the vessel wall is the ability 
of the vessel to remodel. If the radial force is large enough, the vessel can dilate in order to 
accommodate for the stent graft. Several authors have reported these changes in the aneu-
rysm neck after the EVAR [16, 27–33]. In the results of four U.S. phase II trials, neck dilatation 
of 3 mm or more was reported in 13–20% of patients 2 years post EVAR [30]. In a study with 
longer follow-up (4 years) but with smaller sample size, all patients showed at least 2 mm 
of neck dilatation [33]. These results follow a previous description that the self-expandable 
stent-grafts dilate the aortic neck until the nominal diameter of the stent graft is reached [34]. 
This initial adaptation has been reported for almost all the self-expandable endograft-treated 
aortic necks as an adjustment to the devices present and is associated with the percentage 
of oversizing [31]. However, it is unclear, if oversizing is associated with dilatation beyond 
this initial adaptation. Importantly, expansion of the aortic neck to the size of the graft is 
infrequently associated with adverse complications [33]. However, neck dilatation exceeding 
the degree of oversizing can put patients at an increased risk of developing endoleak or graft 
migration [35].
The mechanism, in which, a dilatation larger than the percentage of oversizing can result 
in migration, is thought to be through a reduction in frictional force. Thus, many authors 
have shown that oversizing is positively correlated with neck dilatation [25, 28, 31, 33, 36–38]. 
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Conners et al. [25] reported that oversizing greater than 20% was strongly associated with an 
accelerated late neck expansion. However, the effect of oversizing on dilatation is not black 
and white. In fact, several authors have failed to find any significant correlation when com-
pared to the postoperative diameter [27, 31, 39, 40]. For example, Cao et al. [27] failed to find 
an association between >15% oversizing and neck enlargement. This suggests that oversizing 
is not the only factor involved in the continued expansion of the aortic neck. Different endo-
grafts, stent types, and intramural or hemodynamic conditions could also play a role. It is also 
expected that a patient’s genetics is likely to influence susceptibility to enlargement. Although 
unproven, the intrinsic characteristics of the host aorta could also potentially encourage 
remodeling. If so, markers, such as elastin and collagen may be useful preoperatively in pre-
dicting dilatation.
5.2. Graft migration
Caudal migration of the endovascular graft is one cause of the unsuccessful EVAR. In fact, 
migration following the EVAR has been reported in many studies with rates ranging from 
0% to 45%, varying with different patient populations, follow-up times, and stent-grafts used 
[25, 41–43]. Migration can occur for a number of reasons, but can be best understood in the 
context of the biomechanical forces. If the drag force generated by the blood flow overcomes 
the fixation force between the endograft and aortic wall, the graft will dislodge or migrate. The 
main factors causing this imbalance are continued aortic neck dilatation, pulsatile blood flow 
acting on the seal zone, and mechanical or biological features complicating the attachment. 
Continuous exposure of displacement forces in the direction perpendicular to the endograft 
may cause eccentric graft compression and result in migration [44]. In turn, graft migration can 
lead to other complications, such as, endoleak, occlusion, or rupture. In addition, displacement 
of the stent graft from its apposition site may result in the need for secondary intervention. 
Since graft oversizing has been linked to aortic dilatation and because it plays an important part 
in achieving adequate fixation, correctly oversizing the device can potentially limit migration.
Several studies have investigated the association between oversizing and device migration 
[25, 27, 31, 33, 40, 45–49]. It should be noted that the definition of migration may vary from 
study to study and the amount of migration can ultimately be associated with worse out-
comes. For example, migration of a few millimeters, when compared to complete migration 
into the aneurysm sac, will have significantly different consequences. Oversizing can help 
limit migration by increasing the contact pressure between the vessel wall and device [50]. 
One experimental study found that when oversized an average of 27.7%, 336 g was needed 
to cause migration, as opposed to only 305 g needed to displace grafts oversized an aver-
age of 14.4% [15]. In terms of specific ranges, oversizing >20% seems to require a greater 
pullout force than when sized under 20% [15]. This result can help explain the trend toward 
greater oversizing in patients experiencing migration when oversized a mean of 23.5% vs. 
18.2% [25]. In a larger study of 1082 patients, oversizing 10–30% had the lowest percentage of 
migration [46]. Not oversizing enough, e.g., 10% will require lower magnitudes necessary to 
cause migration compared to devices oversized 20% [51]. Interestingly, migration has been 
suggested to occur after two displacement forces, one to start the movement and the second, 
substantially greater, force to cause significant caudal movement [51].
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As a potential solution for migration, several devices are now made with active fixation (barbs, 
anchors, and pins). Barbs and hooks increase the force needed to dislodge a graft [52]. Yet, 
migration of these grafts can still occur. Thus, when considering the connection of oversizing 
and device migration, the device type may play a crucial role. Increasing data has indicated 
that the biomechanical forces vary between devices with regard to active fixation. Kratzberg 
et al. [48] has shown that as the number of barbs penetrating the aortic wall increases, so does 
the pullout force. However, the displacement force is not significantly affected by oversizing 
until above 30%, at which less force is then needed to dislodge the graft [48, 51]. Importantly, 
grafts oversized >30% can experience significant circumferential deformation/folding at its 
perimeter that negatively affects the attachment [48]. This has been suggested as a major rea-
son for the lower pullout force for grafts oversized >30% compared to those sized 4–10%, 
11–20%, and 21–30% [48]. Sternbergh et al. [40] had similar findings, where they found a 14 
time increase in device migration of 5 mm or more for zenith (active fixation) stent-grafts 
oversized above 30%. Thus, excessive oversizing of aortic stent-grafts with active fixation may 
come with adverse outcomes. Congruently, Vad et al. have proposed sizing these stents up 
to 15% [50].
5.3. Endoleak
Although the pathogenesis of aneurysm enlargement is not completely understood, it is 
generally accepted that the persistent blood flow into the aneurysm sac can lead to further 
expansion and potentially rupture. Thus, incomplete exclusion and resulting perigraft flow, 
termed as endoleak, is a significant complication of EVAR. In particular, type I (incomplete 
seal) and III (mechanical failure of the graft) endoleaks are associated with worse outcomes, 
with type 1A (proximal) leak posing the greatest risk of rupture [14]. Endoleak is amongst the 
most common failures reported with rates ranging from approximately 5 to 40% [14, 53–55]. 
Furthermore, some authors estimate that endoleaks account for over 60% of EVAR reinterven-
tions [56]. Importantly, type I leaks have been attributed to inadequate sizing of endografts 
[14]. Thus, the impact of oversizing and its role in limiting endoleaks has received consider-
able attention.
One mechanism in which oversizing has been suggested to cause endoleak is through infold-
ing of the endograft. As mentioned earlier, higher degrees of oversizing have been linked to 
greater folds [24]. This is significant because the presence of endoleak was subsequently cor-
related to the size of the biggest fold [24]. Another cause of endoleak is due to the expansion of 
the aorta often seen from excessive oversizing. Aortic dilatation can create gaps between the 
endograft and vessel wall, thus allowing the blood to flow into the aneurysm. A third mecha-
nism for endoleaks is from undersizing the aortic stent graft. Undersized grafts exert a weaker 
radial force on the vessel wall and thus can be influenced by smaller displacement forces from 
the pulsatile blood flow. In turn, a decrease in radial force can lead to the development of 
proximal endoleaks [57]. This is likely to occur through the spaces that exist between the stent 
graft and vessel wall. In particular, separation during the decreasing phase of hydrostatic 
pressure has been described [57]. This suggests a delayed deformation as the pressure on the 
attachment site decreases and the aorta relaxes.
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Many studies have investigated endoleaks, but few have looked at the relationship between 
leak and oversizing. One such study of 2146 patients undergoing EVAR with multiple device 
types, showed a decreased risk of proximal endoleak starting at 10% oversizing with narrow 
confidence intervals up to 25% [14]. In another study, oversizing >20% was associated with 
fewer endoleaks (all) and less aneurysm sac enlargement, with the lowest rate of endoleaks 
occurring between 20 and 25% [58]. A mechanics study had similar findings suggesting that 
oversizing 20% helps prevent the occurrence of type I endoleaks [57].
Still, several studies failed to find any significance between oversizing and endoleaks, includ-
ing one that investigated those oversized >30% [40, 54, 59, 60]. Several of these studies were 
difficult to interpret, due to varying population characteristics and methodology. One reason 
for this is that oversizing can be complicated by several factors, one being the conditions at the 
attachment sites. Atherosclerotic plaque, thrombus, and calcifications can interfere with the 
device-wall interface. Intuitively, the presence of plaque between the graft and the vessel low-
ers the frictional coefficient, and thus the force too. Amblard et al. suggested that the plaque 
configuration at the attachment site can be used to predict type I endoleaks [57]. Apposition 
site morphology has also been thought to contribute to the risk of endoleak. Conical necks, in 
particular, can pose increased risk because oversizing in the proximal and distal portions of 
these necks are uneven. This often results in one end being undersized. Thus, greater oversiz-
ing may be appropriate if the characteristics are difficult, such as, a reverse tapered neck [61].
6. Histology of the attachment sites and oversizing
Several adaptations occur to the arterial wall after EVAR. Few studies have looked at the 
effects of oversizing in the abdominal aorta, but the changes seen in the thoracic aorta can still 
provide valuable information. When a stent graft is implanted, a foreign body reaction can 
result. One adaptation is a considerable loss of elasticity, especially at the area of compression, 
regardless of the percentage of oversizing [62]. The same study showed that the max strength 
sustained and the stress supported by fragments of the aortic wall suffered a linear and pro-
gressive loss with increased oversizing [62]. This change can be contributed to a reorganiza-
tion and change in quantity of collagen and elastic fibers distributed around the apposition 
sites. In particular, collagen increases in the aortic wall irrespective of the degree of oversiz-
ing [62] On the other hand, the amount of muscle fibers decrease in the inner third of the 
wall with more oversizing [62]. Importantly, oversizing >40% showed evidence of disruption 
of the fiber content and formation of an aneurysm within the aortic wall [63]. These results 
should be taken with caution, as the biology of the vessel at the infrarenal level may differ.
7. Imaging/preoperative measurements
Accurate sizing of aortic stent-grafts depends on precise preoperative measurements of the 
aorta and iliac arteries. In the past, measurements were done using computerized tomography 
angiography (CTA) axial images, but more recently three-dimensional (3D)  reconstructions 
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with center lumen line (CLL) analysis have taken over [64, 65]. The use of CLL has improved 
the measurement of preoperative diameters and lengths with superior outcomes, and less 
intra- and interobserver variability [64, 66]. Yet, accurate and reproducible measurement 
remains a challenge. Arteries are frequently not perfect circles and thus measurement can 
vary based on the axis. In response, some have proposed alternative methods that are yet to be 
validated, such as using circumference [67]. Thus, while using CLL, it is important to follow 
the manufacturer’s IFU measurement instructions. This has become even more evident, as an 
increasing number of patients undergoing EVAR today have complex apposition site features 
complicating their measurement.
The use of dynamic CTA can also provide some valuable insight for preoperative planning. 
Using dynamic CTA, several authors have found that the aortic and iliac arteries diameter, cir-
cumference, angles, and lengths change during the cardiac cycle [68–70]. Specifically, an asym-
metrical distension is seen with smaller dimensions occurring during diastole. Interestingly, 
preoperative aneurysm neck pulsatility remains similar even years after EVAR, but the base-
line pulsatility is higher for those who experience graft migration [71]. Furthermore, disten-
sion due to dynamic changes in the iliac arteries has been suggested to be a cause of distal 
endoleak [68]. These two observations show how the pulsatility of a patient’s vessels can 
contribute to the over or undersizing of stent-grafts and ultimately lead to poor outcomes. In 
fact, in one study, endografts were inadequately sized for approximately 25% of patients [72]. 
Since pulsatility can vary from patient to patient, measurement of those with complex vessel 
dynamics should be given appropriate attention. Additionally, the fact that vessels expand 
asymmetrically further supports the use of oversizing as a way to limit gaps between the graft 
and vessel wall. To account for these dynamic changes during the cardiac cycle, oversizing as 
much as 20% has been recommended [17, 68].
8. Recent sizing, our experience, conclusions
Advancements in endovascular technique, imaging technology, and device design have led to 
an expanded use of EVAR in the treatment of AAAs.
Aortic stent-grafts create a new channel for the blood flow and thus shield the diseased aor-
tic wall from continued pressure. A number of factors influence the sealing and fixation of 
self-expandable stent-grafts. Some include: (1) vessel shape/diameter, (2) seal zone length, (3) 
angulation/tortuosity, (4) calcification/thrombus, (5) device design (active fixation, material), 
and (6) vessel hemodynamics. Thus, the anatomy and conditions at or around the apposition 
sites are important to consider when sizing.
Some recent studies have provided the degree of oversizing of their cohorts and reported 
outcomes. The ENGAGE study of 1262 patients (approximately one-fifth outside IFU) 
oversized 20% with respect to the inner vessel diameter reported with no stent migra-
tion at 1 year and with satisfactory outcomes [42]. Pitton et al. showed strong results after 
10-year follow-up with 20–25% oversizing of proximal diameters and 10–15% oversizing 
distally [73]. Similarly, in a recent study, 351 patients (mean outer-to-outer wall oversizing 
17.7 ± 10.7%) from 2003 to 2014 showed that >20% oversizing was associated with decreased 
Aortic Aneurysm120
rates of endoleaks (all) compared with 10–20% oversizing, with the lowest rates in patients 
oversized 20–25% [58]. Interestingly, larger infrarenal neck diameters were associated 
with less oversizing. This is suggestive that larger vessels are at risk of being undersized. 
Although the rate of limb occlusion after EVAR is relatively low, it is worth mentioning that 
greater than 15% oversizing at the iliac artery was identified as an independent risk factor 
for limb occlusion [74].
Almost all the recommendations for the degree of oversizing made by manufacturers are 
based on the patients with ideal conditions, such as, straight aortic necks and nontortuous 
iliac arteries. This can be problematic when endografts are delivered to complicated apposi-
tion sites. For consistency in preoperative measurement, surgeons should follow the protocols 
outlined by each device manufacturer, as to which axis measurements should be taken from. 
With regards to oversizing, sizing up to 25% in the aortic neck appears to increase the radial 
force and lower the risk of proximal endoleak. Although inconclusive, additional oversizing 
above 25% may be associated with greater risk of aortic dilatation or graft infolding with the 
potential to cause migration. Ultimately, oversizing, using the current standard of 10–20% 
remains safe and effective. As more complicated EVAR patients present, practice may need to 
be adjusted on a patient-specific basis.
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